PUBLIC CONTRACT · 2018
V 133 - Vacina hexavalente contra dif. Tet. Pert. Hib vip e vhb (dtpahibvipvhb) [udose]
- Contract value
- €1,513,590.00
- Signed on
- 5 April 2018
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 4676680PUBLISHED DESCRIPTION
18i00158 - VACINA HEXAVALENTE CONTRA DIF. TET. PERT. Hib VIP e VHB (DTPaHibVIPVHB) [UDOSE]
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Sanofi Produtos Farmacêuticos, Lda. · Tax ID 500134960
Values and timeline
- Contract price
- €1,513,590.00
- Procedure base price
- €8,905,063.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 20 July 2018
- Award date
- 29 March 2018
- Signing date
- 5 April 2018
- Performance period
- 270 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Not stated
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- CP 2016/13 - Acordo Quadro para fornecimento de Vacinas e Tuberculinas às Instituições e Serviços do Serviço Nacional de Saúde
- Centralised procedure
- Yes
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3414947
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.